Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allorecognition and the spectrum of kidney transplant rejection
Jasper Callemeyn, Baptiste Lamarthée, Alice Koenig, et al.
Kidney International (2021) Vol. 101, Iss. 4, pp. 692-710
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine
Mohammadreza Kasravi, Armin Ahmadi, Amirhesam Babajani, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 135
Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection
Baptiste Lamarthée, Jasper Callemeyn, Yannick Van Herck, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 61
The Molecular Phenotype of Kidney Transplants: Insights From the MMDx Project
Philip F. Halloran, Katelynn S. Madill-Thomsen, J. Reeve
Transplantation (2023) Vol. 108, Iss. 1, pp. 45-71
Open Access | Times Cited: 47
Antibody-mediated Rejection Without Detectable Donor-specific Antibody Releases Donor-derived Cell-free DNA: Results From the Trifecta Study
Philip F. Halloran, J. Reeve, Katelynn S. Madill-Thomsen, et al.
Transplantation (2022) Vol. 107, Iss. 3, pp. 709-719
Open Access | Times Cited: 38
Current Status Regarding Immunosuppressive Treatment in Patients after Renal Transplantation
Kamila Szumilas, Aleksandra Wilk, Piotr Wiśniewski, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10301-10301
Open Access | Times Cited: 38
Automated Urinary Chemokine Assays for Noninvasive Detection of Kidney Transplant Rejection: A Prospective Cohort Study
Elisabet Van Loon, Claire Tinel, Henriëtte de Loor, et al.
American Journal of Kidney Diseases (2023) Vol. 83, Iss. 4, pp. 467-476
Open Access | Times Cited: 28
The Clinical Relevance of the Infiltrating Immune Cell Composition in Kidney Transplant Rejection
Thibaut Vaulet, Jasper Callemeyn, Baptiste Lamarthée, et al.
Journal of the American Society of Nephrology (2024)
Open Access | Times Cited: 8
Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration
Anna Buxeda, Laura Llinàs-Mallol, Javier Gimeno, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 4, pp. 464-474
Open Access | Times Cited: 17
Transcriptomics-based identification of TYROBP and TLR8 as novel macrophage-related biomarkers for the diagnosis of acute rejection after kidney transplantation
Jun Pei, Jie Zhang, Chengjun Yu, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 709, pp. 149790-149790
Closed Access | Times Cited: 6
Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms
Emilie Lebraud, Maëva Eloudzeri, Marion Rabant, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Emerging drugs for antibody-mediated rejection after kidney transplantation: a focus on phase II & III trials
Katharina A. Mayer, Klemens Budde, Bernd Jilma, et al.
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 2, pp. 151-167
Closed Access | Times Cited: 24
The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice
Dennis A. J. van den Broek, Soufian Meziyerh, Klemens Budde, et al.
Transplant International (2023) Vol. 36
Open Access | Times Cited: 15
Pathophysiology of Rejection in Kidney Transplantation
Christina Tamargo, Sam Kant
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 4130-4130
Open Access | Times Cited: 14
Microvascular Inflammation of Kidney Allografts and Clinical Outcomes
Marta Sablik, Aurélie Sannier, Marc Raynaud, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 5
Association of HLA Mismatches and Histology Suggestive of Antibody-Mediated Injury in the Absence of Donor-Specific Anti-HLA Antibodies
Aleksandar Senev, Evelyne Lerut, Maarten Coemans, et al.
Clinical Journal of the American Society of Nephrology (2022) Vol. 17, Iss. 8, pp. 1204-1215
Open Access | Times Cited: 21
Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56dimCD16bright natural killer cells during kidney allograft antibody–mediated rejection showing a new link between adaptive and innate humoral allo-immunity
É. Bailly, Camila Macedo, Jason Ossart, et al.
Kidney International (2023) Vol. 104, Iss. 4, pp. 707-723
Open Access | Times Cited: 12
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”
Dmitry S. Karpov, Anastasiia O. Sosnovtseva, S. V. Pylina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17320-17320
Open Access | Times Cited: 11
Anti-Human Leukocyte Antigen Antibody Detection From Terasaki’s Humoral Theory to Delisting Strategies in 2024
David San Segundo, Alejandra Comins‐Boo, Marcos López‐Hoyos
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 630-630
Open Access
Exhaustion of CD8pos central memory regulatory T cell differentiation is involved in renal allograft rejection
Florian Kälble, Jonas Leonhard, Martin Zeier, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Integration of FTIR Spectroscopy and Machine Learning for Kidney Allograft Rejection: A Complementary Diagnostic Tool
Luís Ramalhete, Rúben Araújo, Miguel Bigotte Vieira, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 846-846
Open Access
Toward Activity and Chronicity Indices for the Evaluation of Kidney Transplant Rejection: A Viewpoint by the Banff Working Group
Maarten Naesens, Lynn D. Cornell, Surya V. Seshan, et al.
Transplantation (2025)
Closed Access
CD38 monoclonal antibody felzartamab for late antibody-mediated rejection: a phase II drug evaluation
Katharina A. Mayer, Klemens Budde, Martina Schatzl, et al.
Expert Opinion on Investigational Drugs (2025)
Open Access
The Many Faces of Protease-Activated Receptor 2 in Kidney Injury
Yuji Oe, Tetsuhiro Tanaka, Nobuyuki Takahashi
Biomedicines (2025) Vol. 13, Iss. 2, pp. 414-414
Open Access
Systemic inflammation is an important risk factor and predictor of graft loss and mortality one year after kidney transplantation
Torbjørn F. Heldal, Anders Åsberg, Thor Ueland, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The immune duality of osteopontin and its therapeutic implications for kidney transplantation
Junto Leung, Lei Qu, Qifa Ye, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top